This webinar will provide attendees with detail on how Oxitec’s self-limiting technology works and provide an overview of the development pathway, from laboratory to field use. We will also cover information about the two well-known and safe genes we use, why female releases are not possible with Oxitec’s OX5034 mosquito, Oxitec’s quality control programs, how tetracycline is used in the UK and not in FL, and other related topics.